Home » Business, Health & Medicine, News & Current Affairs, Pharmaceuticals & Biotech » Non-Small Cell Lung Cancer Therapeutics Market Research Report To 2019: Radiant Insights, Inc.
“Radiant Insights”
RadiantInsights.com has announced the addition of “Global Non-Small Cell Lung Cancer Therapeutics Market Trends, Growth And Forecast Report Up To 2019: Radiant Insights, Inc” Market Research Report to their Database.

About non-small cell lung cancer therapeutics

Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading cause of cancer deaths worldwide, and the incidence of lung cancer is increasing significantly. Lung cancer is the common cause of mortality and morbidity not only in developed countries but also in developing countries. One of the most common types of lung cancer is non-small cell lung cancer. It grows and spreads quite slowly. Smoking is considered as a major cause of lung cancer, although lung cancer also occurs in non-smokers. There are three main types of non-small cell lung cancer: squamous cell (epidermoid) carcinoma, adenocarcinoma, and large cell (undifferentiated) carcinoma. Some of the common symptoms associated with non-small cell lung cancer are chest pain, a cough that does not go away, coughing up blood, fatigue, loss of appetite, losing weight without trying, shortness of breath, and wheezing.

Browse Full Research Report With TOC On ” Global Non-Small Cell Lung Cancer Therapeutics Market 2015-2019 ” at:
http://www.radiantinsights.com/research/global-non-small-cell-lung-cancer-therapeutics-market-2015-2019

Covered in this report

The report covers the current scenario and the growth prospects of the global non-small cell lung cancer therapeutics market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of various drugs used for the treatment of non-small cell lung cancer.

The report covers the Americas, APAC, and Europe; it also covers the landscape of the global non-small cell lung cancer therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • Europe 


Key vendors

  • AstraZeneca
  • Celgene
  • Eli Lilly
  • F. Hoffmann-La Roche
  • Pfizer 


Browse All Reports of This Category at:
www.radiantinsights.com/catalog/pharmaceutical 


Other prominent vendors

  • Abbvie
  • Aetna
  • Agennix
  • Amgen
  • BetaPharma
  • Bionumerik Pharmaceuticals
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • CBT Pharma
  • Celldex Therapeutics
  • Dainippon Pharma
  • Eisai Pharmaceuticals 
  • GlaxoSmithKline
  • Helsinn
  • IMClone Systems
  • IsisPharma
  • Kadmon
  • Kyowa Hakko Kirin
  • MabVax Therapeutics
  • Merck
  • Novartis
  • OncoGenex
  • OSI Pharmaceuticals
  • Peregrine
  • Pierre Fabre
  • Qiagen
  • Sanofi
  • Synta Pharmaceuticals
  • Teva Pharmaceuticals


Latest Report by Radiant Insights:


About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information, visit http://www.radiantinsights.com/

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/global-non-small-cell-lung-cancer-therapeutics-market-2015-2019

Comments are closed.